Cargando…
Diagnostic Challenges and Management of Fibromyalgia
The World Health Organization regards chronic pain to be a public health concern. In clinical medicine, fibromyalgia (FM) is the most prevalent chronic widespread pain disease. In terms of impairment, consumption of health and social resources, and impact on primary and speciality care systems, it h...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580749/ https://www.ncbi.nlm.nih.gov/pubmed/34786265 http://dx.doi.org/10.7759/cureus.18692 |
_version_ | 1784596666843660288 |
---|---|
author | Qureshi, Aniqa G Jha, Saurav K Iskander, John Avanthika, Chaithanya Jhaveri, Sharan Patel, Vithi Hitendra Rasagna Potini, Bhuvana Talha Azam, Ahmad |
author_facet | Qureshi, Aniqa G Jha, Saurav K Iskander, John Avanthika, Chaithanya Jhaveri, Sharan Patel, Vithi Hitendra Rasagna Potini, Bhuvana Talha Azam, Ahmad |
author_sort | Qureshi, Aniqa G |
collection | PubMed |
description | The World Health Organization regards chronic pain to be a public health concern. In clinical medicine, fibromyalgia (FM) is the most prevalent chronic widespread pain disease. In terms of impairment, consumption of health and social resources, and impact on primary and speciality care systems, it has reached worrisome proportions. This disease is frequently managed by primary care providers. Because of its intricacy, fibromyalgia diagnosis and treatment can be difficult. Fibromyalgia is a controversial condition. It might appear ill-defined in comparison to other pain conditions, with no clear knowledge of pathophysiology and hence no particular targeted therapy. This invariably sparks debates and challenges. There is no obvious cut-off point that distinguishes FM from non-FM. The diagnosis of fibromyalgia has been complicated by several factors, including patients' health-seeking behaviour, symptom identification, and physician labelling of the disease. Fibromyalgia is currently considered a centralized pain condition, according to research that has improved our understanding of its etiopathology. A multidisciplinary strategy combining pharmacological and non-pharmacological therapies based on a biopsychosocial paradigm can result in effective therapy. Cultural and psychosocial variables appear to be a recent development in fibromyalgia, and they appear to have a larger influence on physician diagnosis than severe symptom levels in FM patients. Although physicians rely on FM criteria as the only way to classify FM patients in research and clinical settings, some crucial elements of the diagnostic challenge of fibromyalgia remain unsolved - invalidation, psychosocial variables, and diverse illness manifestation are some examples. Beyond the existing constructional scores, physicians' judgment gained in real communicative contexts with patients, appears to be the only dependable route for a more accurate diagnosis for fibromyalgia. We have performed an exhaustive review of the literature using the keywords "Fibromyalgia", "challenges" and "diagnosis" in PubMed and Google Scholar indexes up to September 2021. This article aims to examine the causes, diagnosis, and current treatment protocols of FM, as well as discuss some continuing debates and diagnostic challenges which physicians face in accurately diagnosing fibromyalgia. |
format | Online Article Text |
id | pubmed-8580749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-85807492021-11-15 Diagnostic Challenges and Management of Fibromyalgia Qureshi, Aniqa G Jha, Saurav K Iskander, John Avanthika, Chaithanya Jhaveri, Sharan Patel, Vithi Hitendra Rasagna Potini, Bhuvana Talha Azam, Ahmad Cureus Family/General Practice The World Health Organization regards chronic pain to be a public health concern. In clinical medicine, fibromyalgia (FM) is the most prevalent chronic widespread pain disease. In terms of impairment, consumption of health and social resources, and impact on primary and speciality care systems, it has reached worrisome proportions. This disease is frequently managed by primary care providers. Because of its intricacy, fibromyalgia diagnosis and treatment can be difficult. Fibromyalgia is a controversial condition. It might appear ill-defined in comparison to other pain conditions, with no clear knowledge of pathophysiology and hence no particular targeted therapy. This invariably sparks debates and challenges. There is no obvious cut-off point that distinguishes FM from non-FM. The diagnosis of fibromyalgia has been complicated by several factors, including patients' health-seeking behaviour, symptom identification, and physician labelling of the disease. Fibromyalgia is currently considered a centralized pain condition, according to research that has improved our understanding of its etiopathology. A multidisciplinary strategy combining pharmacological and non-pharmacological therapies based on a biopsychosocial paradigm can result in effective therapy. Cultural and psychosocial variables appear to be a recent development in fibromyalgia, and they appear to have a larger influence on physician diagnosis than severe symptom levels in FM patients. Although physicians rely on FM criteria as the only way to classify FM patients in research and clinical settings, some crucial elements of the diagnostic challenge of fibromyalgia remain unsolved - invalidation, psychosocial variables, and diverse illness manifestation are some examples. Beyond the existing constructional scores, physicians' judgment gained in real communicative contexts with patients, appears to be the only dependable route for a more accurate diagnosis for fibromyalgia. We have performed an exhaustive review of the literature using the keywords "Fibromyalgia", "challenges" and "diagnosis" in PubMed and Google Scholar indexes up to September 2021. This article aims to examine the causes, diagnosis, and current treatment protocols of FM, as well as discuss some continuing debates and diagnostic challenges which physicians face in accurately diagnosing fibromyalgia. Cureus 2021-10-11 /pmc/articles/PMC8580749/ /pubmed/34786265 http://dx.doi.org/10.7759/cureus.18692 Text en Copyright © 2021, Qureshi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Family/General Practice Qureshi, Aniqa G Jha, Saurav K Iskander, John Avanthika, Chaithanya Jhaveri, Sharan Patel, Vithi Hitendra Rasagna Potini, Bhuvana Talha Azam, Ahmad Diagnostic Challenges and Management of Fibromyalgia |
title | Diagnostic Challenges and Management of Fibromyalgia |
title_full | Diagnostic Challenges and Management of Fibromyalgia |
title_fullStr | Diagnostic Challenges and Management of Fibromyalgia |
title_full_unstemmed | Diagnostic Challenges and Management of Fibromyalgia |
title_short | Diagnostic Challenges and Management of Fibromyalgia |
title_sort | diagnostic challenges and management of fibromyalgia |
topic | Family/General Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580749/ https://www.ncbi.nlm.nih.gov/pubmed/34786265 http://dx.doi.org/10.7759/cureus.18692 |
work_keys_str_mv | AT qureshianiqag diagnosticchallengesandmanagementoffibromyalgia AT jhasauravk diagnosticchallengesandmanagementoffibromyalgia AT iskanderjohn diagnosticchallengesandmanagementoffibromyalgia AT avanthikachaithanya diagnosticchallengesandmanagementoffibromyalgia AT jhaverisharan diagnosticchallengesandmanagementoffibromyalgia AT patelvithihitendra diagnosticchallengesandmanagementoffibromyalgia AT rasagnapotinibhuvana diagnosticchallengesandmanagementoffibromyalgia AT talhaazamahmad diagnosticchallengesandmanagementoffibromyalgia |